Osaic Holdings
HAE icon

Osaic Holdings’s Haemonetics HAE Stock Holding History

Osaic Holdings’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19K Sell
253
-45
-15% -$2.89K ﹤0.01% 6214
2026
Q1 		$16.8K Buy
298
+132
+80% +$8.6K ﹤0.01% 5964
2025
Q4 		$13.3K Sell
166
-1,284
-89% -$86.3K ﹤0.01% 6150
2025
Q3 		$71.2K Buy
1,450
+1,310
+936% +$81.1K ﹤0.01% 5066
2025
Q2 		$10.4K Buy
140
+37
+36% +$2.45K ﹤0.01% 6125
2025
Q1 		$6.54K Buy
103
+62
+151% +$4.22K ﹤0.01% 6028
2024
Q4 		$3.2K Buy
+41
New +$3.29K ﹤0.01% 6413
2024
Q3 		– Sell
-209
Closed -$17.3K – 7469
2024
Q2 		$17.3K Buy
209
+47
+29% +$4.13K ﹤0.01% 5444
2024
Q1 		$13.8K Sell
162
-728
-82% -$57.1K ﹤0.01% 5569
2023
Q4 		$76.1K Sell
890
-73
-8% -$6.31K ﹤0.01% 4610
2023
Q3 		$86.3K Sell
963
-334
-26% -$29.8K ﹤0.01% 4613
2023
Q2 		$110K Buy
1,297
+52
+4% +$4.4K ﹤0.01% 4361
2023
Q1 		$103K Buy
1,245
+67
+6% +$5.42K ﹤0.01% 4424
2022
Q4 		$93K Buy
1,178
+48
+4% +$3.86K ﹤0.01% 4496
2022
Q3 		$83K Sell
1,130
-69
-6% -$4.95K ﹤0.01% 4523
2022
Q2 		$78K Buy
1,199
+129
+12% +$7.63K ﹤0.01% 4614
2022
Q1 		$58K Buy
1,070
+138
+15% +$7.5K ﹤0.01% 4992
2021
Q4 		$49K Sell
932
-576
-38% -$35.1K ﹤0.01% 5161
2021
Q3 		$107K Buy
1,508
+98
+7% +$6.18K ﹤0.01% 4466
2021
Q2 		$94K Sell
1,410
-8
-0.6% -$566 ﹤0.01% 4529
2021
Q1 		$158K Sell
1,418
-465
-25% -$57.5K ﹤0.01% 3957
2020
Q4 		$225K Sell
1,883
-124
-6% -$13.3K ﹤0.01% 3370
2020
Q3 		$180K Buy
2,007
+35
+2% +$3.06K ﹤0.01% 3345
2020
Q2 		$178K Buy
1,972
+141
+8% +$14.2K ﹤0.01% 3234
2020
Q1 		$185K Buy
+1,831
New +$199K ﹤0.01% 2936

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings's HAE Position: Q2 2026 in Review

Osaic Holdings reduced its Haemonetics (HAE) stake by 15% in Q2 2026, selling an estimated $2.89K and leaving 253 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #6214.

Osaic Holdings first reported a position in HAE in Q1 2020 and has held it in 25 quarters since. The position peaked at $225K in Q4 2020. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Osaic Holdings held 253 shares of Haemonetics worth $19K as of Q2 2026.
  • Osaic Holdings sold 45 Haemonetics shares in Q2 2026, an estimated $2.89K.
  • Haemonetics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6214 holding.
  • Osaic Holdings first reported a position in Haemonetics in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Haemonetics position peaked at $225K in Q4 2020.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.